XAGE-1 derived peptide vaccine (Kawasaki Medical School)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameXAGE-1 derived peptide vaccine (Kawasaki Medical School)
Drug Alias Namepeptide vaccine (lung cancer)XAGE-1 derived peptide vaccine (lung cancer)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKawasaki Medical School
China Registration ClassN/A

Develop Information

Active CompaniesKawasaki Medical School
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A